Willow Biosciences Revenue vs. EBITDA
| WLLW Stock | CAD 0.09 0.01 6.25% |
Total Revenue | First Reported 2018-09-30 | Previous Quarter 51 K | Current Value 1 M | Quarterly Volatility 257 K |
For Willow Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Willow Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Willow Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Willow Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Willow Biosciences over time as well as its relative position and ranking within its peers.
Willow |
Willow Biosciences EBITDA vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Willow Biosciences's current stock value. Our valuation model uses many indicators to compare Willow Biosciences value to that of its competitors to determine the firm's financial worth. Willow Biosciences is rated third in revenue category among its peers. It is rated second in ebitda category among its peers . At this time, Willow Biosciences' Total Revenue is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Willow Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Willow Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Willow Revenue vs. Competition
Willow Biosciences is rated third in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 37.12 Million. Willow Biosciences holds roughly 1.17 Million in revenue claiming about 3% of equities under Health Care industry.
Willow EBITDA vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Willow Biosciences |
| = | 1.17 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Willow Biosciences |
| = | (11.63 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Willow EBITDA Comparison
Willow Biosciences is currently under evaluation in ebitda category among its peers.
Willow Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Willow Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Willow Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Willow Biosciences' change in net profit over the period of time. It can combine multiple indicators of Willow Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -369 K | -350.6 K | |
| Operating Income | -13.5 M | -12.8 M | |
| Net Loss | -13 M | -12.4 M | |
| Income Tax Expense | -5 K | -4.8 K | |
| Income Before Tax | -13 M | -12.4 M | |
| Total Other Income Expense Net | 424 K | 445.2 K | |
| Net Interest Income | 125 K | 129.5 K | |
| Interest Income | 267 K | 176 K | |
| Net Loss | -13 M | -13.7 M | |
| Net Loss | -13.3 M | -14 M | |
| Change To Netincome | -1.6 M | -1.6 M | |
| Net Loss | (0.10) | (0.11) | |
| Income Quality | 0.84 | 0.44 | |
| Net Income Per E B T | 1.00 | 0.77 |
Willow Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Willow Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Willow Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Willow Biosciences' important profitability drivers and their relationship over time.
Use Willow Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Willow Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Willow Biosciences will appreciate offsetting losses from the drop in the long position's value.Willow Biosciences Pair Trading
Willow Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Willow Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Willow Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Willow Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Willow Biosciences to buy it.
The correlation of Willow Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Willow Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Willow Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Willow Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Willow Biosciences position
In addition to having Willow Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large & Mid Caps ETFs Thematic Idea Now
Large & Mid Caps ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large & Mid Caps ETFs theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large & Mid Caps ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Willow Stock
To fully project Willow Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Willow Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Willow Biosciences' income statement, its balance sheet, and the statement of cash flows.